Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Solta Medical Fraxel re:store Dual laser system receives FDA 510(k) clearance

Solta Medical, a provider of fractional resurfacing and non-invasive skin tightening and a provider in aesthetic skin treatments, has received FDA 510(k) clearance of its Fraxel re:store Dual laser system for the treatment of actinic keratosis (AKs).

The Fraxel system takes the fractional laser technology to the next level by adding a 1927nm wavelength, the first ever application of a Thulium laser in the aesthetics market.

Solta Medical claims that the Fraxel re:store Dual treatment provides superior results for the removal of Aks.

Solta Medical board chairman, president and CEO Stephen Fanning said that Solta Medical continues to develop safe, anti-aging solutions that deliver the best possible results in non-invasive aesthetic treatments.

“With the FDA clearance of our Fraxel re:store Dual system, we are providing our physicians with technology that patients are seeking, specifically in terms of reversing sun damage and treating precancerous skin lesions,” Fanning said.